Biodesix Future Growth
Future criteria checks 1/6
Biodesix is forecast to grow earnings and revenue by 42.6% and 18.3% per annum respectively while EPS is expected to grow by 52.5% per annum.
Key information
42.6%
Earnings growth rate
52.5%
EPS growth rate
Healthcare earnings growth | 17.2% |
Revenue growth rate | 18.3% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 03 May 2024 |
Recent future growth updates
Recent updates
With A 25% Price Drop For Biodesix, Inc. (NASDAQ:BDSX) You'll Still Get What You Pay For
Mar 03Biodesix, Inc.'s (NASDAQ:BDSX) P/S Is Still On The Mark Following 28% Share Price Bounce
Jan 04It's Down 28% But Biodesix, Inc. (NASDAQ:BDSX) Could Be Riskier Than It Looks
Jul 16A Second Look At Biodesix
Oct 18Biodesix expects Q3 revenue above the consensus
Oct 11Biodesix GAAP EPS of -$0.40 beats by $0.07, revenue of $10.95M beats by $2.12M
Aug 04Biodesix: Bad Diagnosis
May 26Analysts' Revenue Estimates For Biodesix, Inc. (NASDAQ:BDSX) Are Surging Higher
Mar 15Need To Know: Analysts Just Made A Substantial Cut To Their Biodesix, Inc. (NASDAQ:BDSX) Estimates
Nov 25Bearing In On Biodesix
Sep 13Time To Worry? Analysts Are Downgrading Their Biodesix, Inc. (NASDAQ:BDSX) Outlook
Aug 16Biodesix: Continued Concerns After The Boom-Bust Cycle
Jul 14Biodesix pops 6% on launch of SARS CoV-2 Neutralization Antibody Test
Jun 15Biodesix announces strategic partnership with Datavant
Jun 04Biodesix enrolls first patient in lung cancer study
May 26Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 99 | -18 | -2 | -3 | 1 |
12/31/2025 | 80 | -32 | -12 | -14 | 3 |
12/31/2024 | 66 | -39 | -29 | -28 | 3 |
12/31/2023 | 49 | -52 | -46 | -23 | N/A |
9/30/2023 | 44 | -63 | -45 | -23 | N/A |
6/30/2023 | 42 | -66 | -46 | -29 | N/A |
3/31/2023 | 41 | -69 | -50 | -40 | N/A |
12/31/2022 | 38 | -65 | -49 | -45 | N/A |
9/30/2022 | 36 | -58 | -45 | -43 | N/A |
6/30/2022 | 31 | -56 | -43 | -41 | N/A |
3/31/2022 | 32 | -52 | -32 | -30 | N/A |
12/31/2021 | 55 | -43 | -31 | -28 | N/A |
9/30/2021 | 74 | -34 | -29 | -27 | N/A |
6/30/2021 | 77 | -32 | -26 | -23 | N/A |
3/31/2021 | 69 | -29 | -31 | -28 | N/A |
12/31/2020 | 46 | -31 | -24 | -21 | N/A |
9/30/2020 | 27 | -33 | -22 | -18 | N/A |
6/30/2020 | 22 | -34 | -23 | -21 | N/A |
3/31/2020 | 23 | -33 | -23 | -21 | N/A |
12/31/2019 | 25 | -31 | -24 | -22 | N/A |
12/31/2018 | 20 | -26 | -18 | -18 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BDSX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: BDSX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: BDSX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: BDSX's revenue (18.3% per year) is forecast to grow faster than the US market (8.2% per year).
High Growth Revenue: BDSX's revenue (18.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BDSX's Return on Equity is forecast to be high in 3 years time